Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dongyun Tu
Observed name:
D Y Tu
Institutions:
Nanjing University of Chinese Medicine,
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College
Observed institutions:
Nanjing University of Chinese Medicine,
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College
ORCID:
0000-0002-6416-2995
Observed ORCID:
0000-0002-6416-2995
OpenAlex ID:
A5090703833
Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma
2023
·
Linyan Xu
, Meng Zhang
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
9
Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era
2021
·
Wei Sang
, Hang Zhou
, et al.
·
International Journal of Hematology
·
8
The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma
2021
·
Wei Sang
, Kailin Xu
, et al.
·
Anti-Cancer Agents in Medicinal Chemistry
·
7
l ‐Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein−Barr virus‐positive Burkitt lymphoma
2022
·
Wei Sang
, Dongyun Tu
, et al.
·
Journal of Biochemical and Molecular Toxicology
·
6
Sodium butyrate induces apoptosis enhanced by JAK2 inhibitor Fedratinib in NK/T-cell lymphoma cell
2026
·
Dongyun Tu
, Tianyi Lu
, et al.
·
Clinical & Translational Oncology
[Effects of L-asparaginase on proliferation, cell cycle and apoptosis of Burkitt lymphoma cell lines].
2021
·
D Y Tu
, M Zhang
, et al.
·
PubMed Central
PDF
Show more works
View as search
Works count:
6
Citation count:
30
H-index:
4
I10-index:
Year
Topic
Type